Medical Molecular Biology

Organisational unit: Research group

More filtering options
  1. 2018
  2. Acoustic Enrichment of Extracellular Vesicles from Biological Fluids

    Anson Ku, Hooi Ching Lim, Mikael Evander, Lilja, H., Thomas Laurell, Stefan Scheding & Yvonne Ceder, 2018, In : Analytical Chemistry. 90, 13, p. 8011-8019 9 p.

    Research output: Contribution to journalArticle

  3. 2017
  4. 2016
  5. The Molecular Evolution of Castration-resistant Prostate Cancer

    Yvonne Ceder, Anders Bjartell, Culig, Z., Rubin, M. A., Tomlins, S. & Visakorpi, T., 2016 Dec, In : European Urology Focus. 2, 5, p. 506-513 8 p.

    Research output: Contribution to journalReview article

  6. The Potential of MicroRNAs as Prostate Cancer Biomarkers.

    Fabris, L., Yvonne Ceder, Chinnaiyan, A. M., Jenster, G. W., Sorensen, K. D., Tomlins, S., Visakorpi, T. & Calin, G. A., 2016, In : European Urology. 70, 2, p. 312-322

    Research output: Contribution to journalReview article

  7. 2015
  8. Exosomal microRNAs as Potential Biomarkers in Castration-resistant Prostate Cancer.

    Haflidadottir, B. & Yvonne Ceder, 2015, In : European Urology. 67, 1, p. 42-43

    Research output: Contribution to journalDebate/Note/Editorial

  9. miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.

    Larne, O., Hagman, Z., Hans Lilja, Anders Bjartell, Edsjö, A. & Yvonne Ceder, 2015, In : Carcinogenesis. 36, 8, p. 858-866

    Research output: Contribution to journalArticle

  10. miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen.

    Larne, O., Östling, P., Haflidadottir, B., Hagman, Z., Aakula, A., Kohonen, P., Kallioniemi, O., Edsjö, A., Anders Bjartell, Hans Lilja, Åke Lundwall & Yvonne Ceder, 2015, In : European Urology. 68, 4, p. 581-588

    Research output: Contribution to journalArticle

  11. 2013
  12. miQ - a novel microRNA based diagnostic and prognostic tool for prostate cancer.

    Larne, O., Martens-Uzunova, E., Hagman, Z., Edsjö, A., Lippolis, G., Vredenbregt-van den Berg, M. S., Anders Bjartell, Jenster, G. & Yvonne Ceder, 2013, In : International Journal of Cancer. 132, 12, p. 2867-2875

    Research output: Contribution to journalArticle

  13. miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.

    Hagman, Z., Haflidadottir, B., Jens Ceder, Larne, O., Anders Bjartell, Hans Lilja, Edsjö, A. & Yvonne Ceder, 2013, In : British Journal of Cancer. 108, 8, p. 1668-1676

    Research output: Contribution to journalArticle

  14. The tumour suppressor miR-34c targets MET in prostate cancer cells.

    Hagman, Z., Haflidadottir, B., Ansari, M., Persson, M., Anders Bjartell, Edsjö, A. & Yvonne Ceder, 2013, In : British Journal of Cancer. 109, 5, p. 1271-1278

    Research output: Contribution to journalArticle

  15. Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1.

    Haflidadottir, B., Larne, O., Myriam Martin, Persson, M., Edsjö, A., Anders Bjartell & Yvonne Ceder, 2013, In : PLoS ONE. 8, 8, e72400.

    Research output: Contribution to journalArticle

  16. 2011
  17. Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells.

    Ostling, P., Leivonen, S-K., Aakula, A., Kohonen, P., Mäkelä, R., Hagman, Z., Edsjö, A., Kangaspeska, S., Edgren, H., Nicorici, D., Anders Bjartell, Yvonne Ceder, Perälä, M. & Kallioniemi, O., 2011, In : Cancer Research. 71, p. 1956-1967

    Research output: Contribution to journalArticle

  18. 2010
  19. miR-34c is down regulated in prostate cancer and exerts tumor suppressive functions.

    Hagman, Z., Larne, O., Edsjö, A., Anders Bjartell, Ehrnström, R., David Ulmert, Hans Lilja & Yvonne Ceder, 2010, In : International Journal of Cancer. 127, 12, p. 2768-2776

    Research output: Contribution to journalArticle